CJC-1295 NO DAC (Mod GRF 1-29) (5mg)

Buy CJC-1295 No DAC UK | Modified GRF 1-29 Peptide

Buy CJC-1295 No DAC UK, also known as Modified GRF (1-29), is a high-purity synthetic peptide supplied by Peptide House UK for laboratory research purposes only. Researchers widely study this compound because it mimics the activity of growth hormone-releasing hormone (GHRH) while offering a shorter and more controlled activity profile than DAC-modified versions.

Importantly, many researchers prefer CJC-1295 No DAC when investigating pulsatile growth hormone release patterns. Therefore, it has become a popular peptide in studies involving hormonal signalling, IGF-1 activity, metabolic regulation, and recovery pathways.

Why Researchers Choose CJC-1295 No DAC

Researchers frequently choose CJC-1295 No DAC because it provides greater control over timing and signalling compared to extended-release alternatives. In addition, its shorter half-life allows for more precise experimental protocols.

Furthermore, its mechanism closely resembles natural GHRH activity, making it highly relevant in endocrine and hormone pathway research.

• Growth hormone pathway investigations
• IGF-1 signalling research
• Pulsatile hormone release studies
• Metabolic function models
• Recovery and regeneration research

Mechanism of Action (Research Context)

CJC-1295 No DAC is studied for its ability to bind to GHRH receptors located on pituitary somatotroph cells. As a result, researchers investigate how it activates intracellular pathways associated with growth hormone release.

Specifically, studies focus on signalling cascades involving cAMP production, protein kinase activation, and gene transcription processes linked to endocrine function.

• GHRH receptor activation models
• cAMP signalling pathway research
• Protein kinase activity studies
• Growth hormone release investigations

Consequently, researchers often use CJC-1295 No DAC when analysing natural hormone pulsatility and physiological signalling patterns.

Key Research Applications

1. Growth Hormone & IGF-1 Research

CJC-1295 No DAC is primarily studied for its relationship with growth hormone and IGF-1 pathways. Therefore, researchers frequently include it in experimental models examining endocrine regulation and anabolic signalling.

• Growth hormone secretion studies
• IGF-1 pathway investigations
• Endocrine signalling models
• Anabolic research systems

2. Recovery & Regeneration Research

Researchers also investigate CJC-1295 No DAC in studies involving tissue recovery and regeneration. Furthermore, growth hormone signalling remains closely linked to biological repair processes and cellular maintenance pathways.

• Recovery pathway research
• Tissue regeneration studies
• Cellular repair investigations
• Regenerative biology models

3. Muscle & Performance Research

Many experimental models explore how growth hormone pathways influence lean tissue development and performance-related biological processes. As a result, CJC-1295 No DAC remains highly relevant within performance peptide research clusters.

• Lean tissue research
• Muscle development studies
• Performance signalling models
• Exercise recovery investigations

4. Metabolic Function Research

Researchers continue studying growth hormone pathways because they influence energy utilisation, nutrient signalling, and metabolic activity. Therefore, CJC-1295 No DAC frequently appears in broader metabolic research protocols.

• Metabolic regulation studies
• Energy signalling investigations
• Nutrient utilisation models
• Hormonal regulation research

5. Synergistic Peptide Research

CJC-1295 No DAC is frequently studied alongside growth hormone secretagogues such as Ipamorelin. In these research models, scientists investigate how dual-pathway stimulation affects growth hormone signalling dynamics.

Moreover, this combination allows researchers to examine both GHRH receptor activation and ghrelin receptor activity within the same experimental framework.

• GHRH and ghrelin pathway studies
• Peptide synergy investigations
• Hormonal signalling amplification models
• Multi-pathway endocrine research

Chemical Profile

• Molecular Formula: C152H252N44O42
• Molecular Weight: 3367.9 g/mol
• Alternative Names: Modified GRF (1-29), CJC-1295 No DAC

Internal Research Clusters

Growth Hormone Research Cluster

• Ipamorelin 10mg
• CJC-1295 DAC
• Hormonal Signalling Peptides

Muscle Growth & Performance Cluster

• MGF Peptide
• IGF-1 LR3
• Muscle Growth & Performance Peptides

Recovery & Regeneration Cluster

• BPC-157 10mg
• TB-500 Peptide
• Healing & Recovery Peptides

Metabolic & Wellness Cluster

• MOTS-c
• AOD-9604
• Metabolic & Wellness Peptides

Why Buy from Peptide House UK?

• Premium research-grade peptides
• High-purity synthesis standards
• Strict batch quality control
• Secure UK shipping and checkout
• Trusted UK peptide supplier
• Dedicated support for research customers

Important Notice

CJC-1295 No DAC is supplied strictly for laboratory and scientific research purposes only. It is not intended for human consumption, medical use, veterinary use, or diagnostic applications.

At Peptide House UK, we ensure every peptide meets strict research-grade standards to support reliable and consistent laboratory outcomes.